Biotechnology Stocks I Performance Guide: Beam Therapeutics Inc. (BEAM)
BEAM has no dividends.
Table and Chart of BEAM Performance
See what a $1,000 investment in BEAM is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BEAM Returns | |
|---|---|
| Start Date | Mar-31-2020 |
| Start Price | $18.00 |
| End Date | Sep-19-2024 |
| End Price | $26.04 |
| # Prices | 55 |
| Min Date | Apr-30-2020 |
| Min Price | $15.95 |
| Max Date | Jun-30-2021 |
| Max Price | $128.71 |
| Total Return | 44.67% |
| Annualized Return | 8.39% |
| Current Value of $1,000 Purchase | $1,447 |
| Number Returns | 1,485 |
| Average Return | 9.03% |
| Number Profitable Returns | 508 |
| Percent Profitable Returns | 34.21% |
| Number Unprofitable Returns | 977 |
| Percent Unprofitable Returns | 65.79% |
| Profitable to Unprofitable Returns Ratio | 0.52 |
| BEAM Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $2,024 |
| Beta | -7.030 | Price to Sales |
| Earnings per Share | $0.0000 |
| PE Ratio | -162880000 |
| PE to Growth Ratio | None |
| Price to Book | 5.96 |
| PRICE DATA | |
| 52 Week High | $1.854 |
| 52 Week Low | $49.5 |
| Analyst Target Price | $-0.415 |
| 50-Day Moving Average | $16.95 |
| 200-Day Moving Average | $26.27 |
| FINANCIAL DATA | |
| Revenue per Share | $-1.62 |
| Revenue | $0 |
| Profit Margin | 435.3% |
| Return on Equity | -8.82% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BEAM Compare Returns with S&P 500
BEAM Trendline Chart
BEAM Moving Average Chart
BEAM Stock Return Map - See Patterns of Gains and Losses
BEAM Stock Returns/Purchase Dates